Global Biosimulation Market Size study, By Product (Software, Services), By Application (Drug Development, Drug Discovery, Others), By Delivery Model (Subscription Models, Ownership Models), By End-Use (Pharmaceutical & Biotechnology Companies, CROs, Regulatory Authorities, Academic Research Institutions), and Regional Forecasts 2022-2028
Global Biosimulation Market is valued at approximately USD 2.4 Billion in 2021 and is anticipated to grow with a healthy growth rate of more than 16.2% over the forecast period 2022-2028.
The use of computer software to simulate biological processes is known as biosimulation. A predictive and analytical tool called biosimulation is used in the drug discovery process to forecast the results of ongoing experimental trials. By running illness simulations, virtual clinical trials of novel pharmacological medications under development can be carried out. Biosimulation software has several uses in the pharmaceutical drug discovery and development process since it can help pharmaceutical companies find novel medications faster and more affordably. Increasing need to reduce drug discovery and development costs, as well as increasing investments in the life sciences industry, are factors that are accelerating the global market demand. For instance, in a study from April 2021 that was published in the National Center for Biotechnology Information, in silico modelling utilizing the biosimulation tool BIOiSIM was done using preclinical in vitro and in vivo datasets that were well-known. The goal of the trial was to expedite the repurposing of therapies for pulmonary hypertension and the development of COVID-19-fighting medications. Consequentially, increasing use of personalized medicine and rising technological advancements stimulate market growth in the approaching years. However, a lack of skills & expertise impedes the growth of the market over the forecast period of 2022-2028.
The key regions considered for the global Biosimulation market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the presence of key market players, increasing adoption of digitalization in healthcare, and rising prevalence of chronic diseases. Whereas, Asia Pacific is anticipated to exhibit a significant growth rate over the forecast period 2022-2028. Factors such as rising research and development activities, and rising initiatives by public and private players would create lucrative growth prospects for the Biosimulation market across the Asia Pacific region.
Major market players included in this report are:
Certara, USA
Simulations Plus
Dassault Syst?mes
Schrцdinger, Inc.
Advanced Chemistry Development
Chemical Computing Group ULC
Physiomics Plc
Rosa & Co. LLC
Biosimulation Consulting Inc.
Genedata AG
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Software
Services
By Application:
Drug Development
Drug Discovery
Others
By Delivery Model:
Subscription Models
Ownership Models
By End-Use:
Pharmaceutical & Biotechnology Companies
CROs
Regulatory Authorities
Academic Research Institutions
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028
Target Audience of the Global Biosimulation Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
The use of computer software to simulate biological processes is known as biosimulation. A predictive and analytical tool called biosimulation is used in the drug discovery process to forecast the results of ongoing experimental trials. By running illness simulations, virtual clinical trials of novel pharmacological medications under development can be carried out. Biosimulation software has several uses in the pharmaceutical drug discovery and development process since it can help pharmaceutical companies find novel medications faster and more affordably. Increasing need to reduce drug discovery and development costs, as well as increasing investments in the life sciences industry, are factors that are accelerating the global market demand. For instance, in a study from April 2021 that was published in the National Center for Biotechnology Information, in silico modelling utilizing the biosimulation tool BIOiSIM was done using preclinical in vitro and in vivo datasets that were well-known. The goal of the trial was to expedite the repurposing of therapies for pulmonary hypertension and the development of COVID-19-fighting medications. Consequentially, increasing use of personalized medicine and rising technological advancements stimulate market growth in the approaching years. However, a lack of skills & expertise impedes the growth of the market over the forecast period of 2022-2028.
The key regions considered for the global Biosimulation market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the presence of key market players, increasing adoption of digitalization in healthcare, and rising prevalence of chronic diseases. Whereas, Asia Pacific is anticipated to exhibit a significant growth rate over the forecast period 2022-2028. Factors such as rising research and development activities, and rising initiatives by public and private players would create lucrative growth prospects for the Biosimulation market across the Asia Pacific region.
Major market players included in this report are:
Certara, USA
Simulations Plus
Dassault Syst?mes
Schrцdinger, Inc.
Advanced Chemistry Development
Chemical Computing Group ULC
Physiomics Plc
Rosa & Co. LLC
Biosimulation Consulting Inc.
Genedata AG
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Software
Services
By Application:
Drug Development
Drug Discovery
Others
By Delivery Model:
Subscription Models
Ownership Models
By End-Use:
Pharmaceutical & Biotechnology Companies
CROs
Regulatory Authorities
Academic Research Institutions
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028
Target Audience of the Global Biosimulation Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
1.2.1. Biosimulation Market, by Region, 2020-2028 (USD Billion)
1.2.2. Biosimulation Market, by Product, 2020-2028 (USD Billion)
1.2.3. Biosimulation Market, by Application, 2020-2028 (USD Billion)
1.2.4. Biosimulation Market, by Delivery Model, 2020-2028 (USD Billion)
1.2.5. Biosimulation Market, by End-Use, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL BIOSIMULATION MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL BIOSIMULATION MARKET DYNAMICS
3.1. Biosimulation Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Increasing need to reduce drug discovery and development costs
3.1.1.2. Increasing investments in the life sciences industry
3.1.2. Market Challenges
3.1.2.1. Lack of skills and expertise
3.1.3. Market Opportunities
3.1.3.1. Increasing use of personalized medicine
3.1.3.2. Rising Technological advancements
CHAPTER 4. GLOBAL BIOSIMULATION MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 Market scenario
CHAPTER 6. GLOBAL BIOSIMULATION MARKET, BY PRODUCT
6.1. Market Snapshot
6.2. Global Biosimulation Market by Product, Performance - Potential Analysis
6.3. Global Biosimulation Market Estimates & Forecasts by Product, 2018-2028 (USD Billion)
6.4. Biosimulation Market, Sub Segment Analysis
6.4.1. Software
6.4.2. Services
CHAPTER 7. GLOBAL BIOSIMULATION MARKET, BY APPLICATION
7.1. Market Snapshot
7.2. Global Biosimulation Market by Application, Performance - Potential Analysis
7.3. Global Biosimulation Market Estimates & Forecasts by Application, 2018-2028 (USD Billion)
7.4. Biosimulation Market, Sub Segment Analysis
7.4.1. Drug Development
7.4.2. Drug Discovery
7.4.3. Others
CHAPTER 8. GLOBAL BIOSIMULATION MARKET, BY DELIVERY MODEL
8.1. Market Snapshot
8.2. Global Biosimulation Market by Delivery Model, Performance - Potential Analysis
8.3. Global Biosimulation Market Estimates & Forecasts by Delivery Model, 2018-2028 (USD Billion)
8.4. Biosimulation Market, Sub Segment Analysis
8.4.1. Subscription Models
8.4.2. Ownership Models
CHAPTER 9. GLOBAL BIOSIMULATION MARKET, BY END-USE
9.1. Market Snapshot
9.2. Global Biosimulation Market by End-Use, Performance - Potential Analysis
9.3. Global Biosimulation Market Estimates & Forecasts by End-Use, 2018-2028 (USD Billion)
9.4. Biosimulation Market, Sub Segment Analysis
9.4.1. Pharmaceutical & Biotechnology Companies
9.4.2. CROs
9.4.3. Regulatory Authorities
9.4.4. Academic Research Institutions
CHAPTER 10. GLOBAL BIOSIMULATION MARKET, REGIONAL ANALYSIS
10.1. Biosimulation Market, Regional Market Snapshot
10.2. North America Biosimulation Market
10.2.1. U.S. Biosimulation Market
10.2.1.1. Product breakdown estimates & forecasts, 2018-2028
10.2.1.2. Application breakdown estimates & forecasts, 2018-2028
10.2.1.3. Delivery model breakdown estimates & forecasts, 2018-2028
10.2.1.4. End-Use breakdown estimates & forecasts, 2018-2028
10.2.2. Canada Biosimulation Market
10.3. Europe Biosimulation Market Snapshot
10.3.1. U.K. Biosimulation Market
10.3.2. Germany Biosimulation Market
10.3.3. France Biosimulation Market
10.3.4. Spain Biosimulation Market
10.3.5. Italy Biosimulation Market
10.3.6. Rest of Europe Biosimulation Market
10.4. Asia-Pacific Biosimulation Market Snapshot
10.4.1. China Biosimulation Market
10.4.2. India Biosimulation Market
10.4.3. Japan Biosimulation Market
10.4.4. Australia Biosimulation Market
10.4.5. South Korea Biosimulation Market
10.4.6. Rest of Asia Pacific Biosimulation Market
10.5. Latin America Biosimulation Market Snapshot
10.5.1. Brazil Biosimulation Market
10.5.2. Mexico Biosimulation Market
10.6. Rest of The World Biosimulation Market
CHAPTER 11. COMPETITIVE INTELLIGENCE
11.1. Top Market Strategies
11.2. Company Profiles
11.2.1. Certara, USA
11.2.1.1. Key Information
11.2.1.2. Overview
11.2.1.3. Financial (Subject to Data Availability)
11.2.1.4. Product Summary
11.2.1.5. Recent Developments
11.2.2. Simulations Plus
11.2.3. Dassault Syst?mes
11.2.4. Schrцdinger, Inc.
11.2.5. Advanced Chemistry Development
11.2.6. Chemical Computing Group ULC
11.2.7. Physiomics Plc
11.2.8. Rosa & Co. LLC
11.2.9. Biosimulation Consulting Inc.
11.2.10. Genedata AG
CHAPTER 12. RESEARCH PROCESS
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
1.2.1. Biosimulation Market, by Region, 2020-2028 (USD Billion)
1.2.2. Biosimulation Market, by Product, 2020-2028 (USD Billion)
1.2.3. Biosimulation Market, by Application, 2020-2028 (USD Billion)
1.2.4. Biosimulation Market, by Delivery Model, 2020-2028 (USD Billion)
1.2.5. Biosimulation Market, by End-Use, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL BIOSIMULATION MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL BIOSIMULATION MARKET DYNAMICS
3.1. Biosimulation Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Increasing need to reduce drug discovery and development costs
3.1.1.2. Increasing investments in the life sciences industry
3.1.2. Market Challenges
3.1.2.1. Lack of skills and expertise
3.1.3. Market Opportunities
3.1.3.1. Increasing use of personalized medicine
3.1.3.2. Rising Technological advancements
CHAPTER 4. GLOBAL BIOSIMULATION MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 Market scenario
CHAPTER 6. GLOBAL BIOSIMULATION MARKET, BY PRODUCT
6.1. Market Snapshot
6.2. Global Biosimulation Market by Product, Performance - Potential Analysis
6.3. Global Biosimulation Market Estimates & Forecasts by Product, 2018-2028 (USD Billion)
6.4. Biosimulation Market, Sub Segment Analysis
6.4.1. Software
6.4.2. Services
CHAPTER 7. GLOBAL BIOSIMULATION MARKET, BY APPLICATION
7.1. Market Snapshot
7.2. Global Biosimulation Market by Application, Performance - Potential Analysis
7.3. Global Biosimulation Market Estimates & Forecasts by Application, 2018-2028 (USD Billion)
7.4. Biosimulation Market, Sub Segment Analysis
7.4.1. Drug Development
7.4.2. Drug Discovery
7.4.3. Others
CHAPTER 8. GLOBAL BIOSIMULATION MARKET, BY DELIVERY MODEL
8.1. Market Snapshot
8.2. Global Biosimulation Market by Delivery Model, Performance - Potential Analysis
8.3. Global Biosimulation Market Estimates & Forecasts by Delivery Model, 2018-2028 (USD Billion)
8.4. Biosimulation Market, Sub Segment Analysis
8.4.1. Subscription Models
8.4.2. Ownership Models
CHAPTER 9. GLOBAL BIOSIMULATION MARKET, BY END-USE
9.1. Market Snapshot
9.2. Global Biosimulation Market by End-Use, Performance - Potential Analysis
9.3. Global Biosimulation Market Estimates & Forecasts by End-Use, 2018-2028 (USD Billion)
9.4. Biosimulation Market, Sub Segment Analysis
9.4.1. Pharmaceutical & Biotechnology Companies
9.4.2. CROs
9.4.3. Regulatory Authorities
9.4.4. Academic Research Institutions
CHAPTER 10. GLOBAL BIOSIMULATION MARKET, REGIONAL ANALYSIS
10.1. Biosimulation Market, Regional Market Snapshot
10.2. North America Biosimulation Market
10.2.1. U.S. Biosimulation Market
10.2.1.1. Product breakdown estimates & forecasts, 2018-2028
10.2.1.2. Application breakdown estimates & forecasts, 2018-2028
10.2.1.3. Delivery model breakdown estimates & forecasts, 2018-2028
10.2.1.4. End-Use breakdown estimates & forecasts, 2018-2028
10.2.2. Canada Biosimulation Market
10.3. Europe Biosimulation Market Snapshot
10.3.1. U.K. Biosimulation Market
10.3.2. Germany Biosimulation Market
10.3.3. France Biosimulation Market
10.3.4. Spain Biosimulation Market
10.3.5. Italy Biosimulation Market
10.3.6. Rest of Europe Biosimulation Market
10.4. Asia-Pacific Biosimulation Market Snapshot
10.4.1. China Biosimulation Market
10.4.2. India Biosimulation Market
10.4.3. Japan Biosimulation Market
10.4.4. Australia Biosimulation Market
10.4.5. South Korea Biosimulation Market
10.4.6. Rest of Asia Pacific Biosimulation Market
10.5. Latin America Biosimulation Market Snapshot
10.5.1. Brazil Biosimulation Market
10.5.2. Mexico Biosimulation Market
10.6. Rest of The World Biosimulation Market
CHAPTER 11. COMPETITIVE INTELLIGENCE
11.1. Top Market Strategies
11.2. Company Profiles
11.2.1. Certara, USA
11.2.1.1. Key Information
11.2.1.2. Overview
11.2.1.3. Financial (Subject to Data Availability)
11.2.1.4. Product Summary
11.2.1.5. Recent Developments
11.2.2. Simulations Plus
11.2.3. Dassault Syst?mes
11.2.4. Schrцdinger, Inc.
11.2.5. Advanced Chemistry Development
11.2.6. Chemical Computing Group ULC
11.2.7. Physiomics Plc
11.2.8. Rosa & Co. LLC
11.2.9. Biosimulation Consulting Inc.
11.2.10. Genedata AG
CHAPTER 12. RESEARCH PROCESS
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Biosimulation Market, report scope
TABLE 2. Global Biosimulation Market estimates & forecasts by Region 2018-2028 (USD Billion)
TABLE 3. Global Biosimulation Market estimates & forecasts by Product 2018-2028 (USD Billion)
TABLE 4. Global Biosimulation Market estimates & forecasts by Application 2018-2028 (USD Billion)
TABLE 5. Global Biosimulation Market estimates & forecasts by Delivery Model 2018-2028 (USD Billion)
TABLE 6. Global Biosimulation Market estimates & forecasts by End-Use 2018-2028 (USD Billion)
TABLE 7. Global Biosimulation Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 8. Global Biosimulation Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 9. Global Biosimulation Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 10. Global Biosimulation Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 11. Global Biosimulation Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 12. Global Biosimulation Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 13. Global Biosimulation Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 14. Global Biosimulation Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 15. Global Biosimulation Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 16. Global Biosimulation Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 17. U.S. Biosimulation Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 18. U.S. Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 19. U.S. Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 20. Canada Biosimulation Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 21. Canada Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 22. Canada Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 23. UK Biosimulation Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 24. UK Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 25. UK Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 26. Germany Biosimulation Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 27. Germany Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 28. Germany Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 29. RoE Biosimulation Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 30. RoE Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 31. RoE Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 32. China Biosimulation Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 33. China Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 34. China Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 35. India Biosimulation Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 36. India Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 37. India Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 38. Japan Biosimulation Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 39. Japan Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 40. Japan Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 41. RoAPAC Biosimulation Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 42. RoAPAC Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 43. RoAPAC Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 44. Brazil Biosimulation Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 45. Brazil Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 46. Brazil Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 47. Mexico Biosimulation Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 48. Mexico Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 49. Mexico Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 50. RoLA Biosimulation Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 51. RoLA Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 52. RoLA Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 53. Row Biosimulation Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 54. Row Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 55. Row Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 56. List of secondary sources, used in the study of global Biosimulation Market
TABLE 57. List of primary sources, used in the study of global Biosimulation Market
TABLE 58. Years considered for the study
TABLE 59. Exchange rates considered
TABLE 1. Global Biosimulation Market, report scope
TABLE 2. Global Biosimulation Market estimates & forecasts by Region 2018-2028 (USD Billion)
TABLE 3. Global Biosimulation Market estimates & forecasts by Product 2018-2028 (USD Billion)
TABLE 4. Global Biosimulation Market estimates & forecasts by Application 2018-2028 (USD Billion)
TABLE 5. Global Biosimulation Market estimates & forecasts by Delivery Model 2018-2028 (USD Billion)
TABLE 6. Global Biosimulation Market estimates & forecasts by End-Use 2018-2028 (USD Billion)
TABLE 7. Global Biosimulation Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 8. Global Biosimulation Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 9. Global Biosimulation Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 10. Global Biosimulation Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 11. Global Biosimulation Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 12. Global Biosimulation Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 13. Global Biosimulation Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 14. Global Biosimulation Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 15. Global Biosimulation Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 16. Global Biosimulation Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 17. U.S. Biosimulation Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 18. U.S. Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 19. U.S. Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 20. Canada Biosimulation Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 21. Canada Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 22. Canada Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 23. UK Biosimulation Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 24. UK Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 25. UK Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 26. Germany Biosimulation Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 27. Germany Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 28. Germany Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 29. RoE Biosimulation Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 30. RoE Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 31. RoE Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 32. China Biosimulation Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 33. China Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 34. China Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 35. India Biosimulation Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 36. India Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 37. India Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 38. Japan Biosimulation Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 39. Japan Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 40. Japan Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 41. RoAPAC Biosimulation Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 42. RoAPAC Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 43. RoAPAC Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 44. Brazil Biosimulation Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 45. Brazil Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 46. Brazil Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 47. Mexico Biosimulation Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 48. Mexico Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 49. Mexico Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 50. RoLA Biosimulation Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 51. RoLA Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 52. RoLA Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 53. Row Biosimulation Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 54. Row Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 55. Row Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 56. List of secondary sources, used in the study of global Biosimulation Market
TABLE 57. List of primary sources, used in the study of global Biosimulation Market
TABLE 58. Years considered for the study
TABLE 59. Exchange rates considered
LIST OF FIGURES
FIG 1. Global Biosimulation Market, research methodology
FIG 2. Global Biosimulation Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Biosimulation Market, key trends 2021
FIG 5. Global Biosimulation Market, growth prospects 2022-2028
FIG 6. Global Biosimulation Market, porters 5 force model
FIG 7. Global Biosimulation Market, pest analysis
FIG 8. Global Biosimulation Market, value chain analysis
FIG 9. Global Biosimulation Market by segment, 2018 & 2028 (USD Billion)
FIG 10. Global Biosimulation Market by segment, 2018 & 2028 (USD Billion)
FIG 11. Global Biosimulation Market by segment, 2018 & 2028 (USD Billion)
FIG 12. Global Biosimulation Market by segment, 2018 & 2028 (USD Billion)
FIG 13. Global Biosimulation Market by segment, 2018 & 2028 (USD Billion)
FIG 14. Global Biosimulation Market, regional snapshot 2018 & 2028
FIG 15. North America Biosimulation Market 2018 & 2028 (USD Billion)
FIG 16. Europe Biosimulation Market 2018 & 2028 (USD Billion)
FIG 17. Asia Pacific Biosimulation Market 2018 & 2028 (USD Billion)
FIG 18. Latin America Biosimulation Market 2018 & 2028 (USD Billion)
FIG 19. Global Biosimulation Market, company Market share analysis (2021)
FIG 1. Global Biosimulation Market, research methodology
FIG 2. Global Biosimulation Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Biosimulation Market, key trends 2021
FIG 5. Global Biosimulation Market, growth prospects 2022-2028
FIG 6. Global Biosimulation Market, porters 5 force model
FIG 7. Global Biosimulation Market, pest analysis
FIG 8. Global Biosimulation Market, value chain analysis
FIG 9. Global Biosimulation Market by segment, 2018 & 2028 (USD Billion)
FIG 10. Global Biosimulation Market by segment, 2018 & 2028 (USD Billion)
FIG 11. Global Biosimulation Market by segment, 2018 & 2028 (USD Billion)
FIG 12. Global Biosimulation Market by segment, 2018 & 2028 (USD Billion)
FIG 13. Global Biosimulation Market by segment, 2018 & 2028 (USD Billion)
FIG 14. Global Biosimulation Market, regional snapshot 2018 & 2028
FIG 15. North America Biosimulation Market 2018 & 2028 (USD Billion)
FIG 16. Europe Biosimulation Market 2018 & 2028 (USD Billion)
FIG 17. Asia Pacific Biosimulation Market 2018 & 2028 (USD Billion)
FIG 18. Latin America Biosimulation Market 2018 & 2028 (USD Billion)
FIG 19. Global Biosimulation Market, company Market share analysis (2021)
